|
2024 GESA Dr Falk Pharma for 2025 |
Dr Falk Pharma |
Robert Gilmore |
$40,000 exc. |
1 year |
01 January 2025 |
|
|
A randomised, open-label, non-inferiority study of upadacitinib compared with oral corticosteroid for induction of remission in Moderate to Severe Ulcerative Colitis and Crohns Disease - INDUCE |
|
|
Mater Hospital Brisbane, South Brisbane |
|
|
2024 GESA Project Grant |
GESA |
Andrew Graham Cox |
$50,000 exc. |
12 months |
01 December 2024 |
|
|
Exploring the role of Bile acid dysregulation in liver cancer associated cachexia |
|
|
Peter MacCallum Cancer Centre, Parkville |
|
|
2024 GESA Project Grant |
GESA |
Edward M Giles |
$50,000 exc. |
12 months |
01 December 2024 |
|
|
Interferon Epsilon as an epithelial regulator of inflammatory bowel disease |
|
|
Monash Health, Clayton |
|
|
2024 GESA Project Grant |
GESA |
Katharine Irvine |
$50,000 exc. |
12 months |
01 December 2024 |
|
|
Hepatic delivery of Colony Stimulating Factor 1 mRNA to promote liver repair |
|
|
Mater Research - The University of Queensland, Woolloongabba |
|
|
2024 GESA Project Grant |
GESA |
Scott A Read |
$50,000 exc. |
12 months |
01 December 2024 |
|
|
Developing a memory NK cell-based cellular therapy targeting hepatitis B virus |
|
|
Western Sydney University, Westmead |
|
|
2024 GESA Project Grant |
GESA |
Erin Leigh Symonds |
$50,000 exc. |
12 months |
01 December 2024 |
|
|
A new colonoscopy triage tool for young patients with iron deficiency. |
|
|
Flinders Medical Centre, Bedford Park |
|
|
2024 GESA Project Grant |
GESA |
susan l woods |
$50,000 exc. |
12 months |
01 December 2024 |
|
|
Genetic engineering of E. coli Nissle to improve biosafety and therapeutic precision. |
|
|
The University of Adelaide, Adelaide |
|
|
2024 GESA Mid-Career Grant Award |
GESA |
Andrew Graham Cox |
$25,000 exc. |
1 year |
30 September 2024 |
|
|
Exploring the role that metabolism and plasticity play in NRF2-driven liver cancer |
|
|
Peter MacCallum Cancer Centre, Melbourne |
|
|
2024 GESA Mostyn Family Grant |
The Mostyn Family Foundation |
Rebekah Taylor de Nys |
$30,000 exc. |
1 year |
30 September 2024 |
|
|
Investigating the role of E. coli Nissle biofilm formation in colorectal cancer tumour colonization. |
|
|
SAHMRI, Adelaide |
|
|
2024 GESA Rose Amarant Grant |
Rose Anne Amarant Charitable Trust |
Rupert W Leong |
$7,500 exc. |
6 months |
30 September 2024 |
|
|
Persistence Australian National IBD Cohort (PANIC6). Determining the effectiveness and cost-effectiveness of advanced therapies in Crohns disease and ulcerative colitis. |
|
|
Concord Repatriation General Hospital, Concord West |
|
|
2023 GESA Dr Falk Pharma Research Grant for 2024 |
Dr Falk Pharma |
Robert Venning Bryant |
$27,000 exc. |
12 months |
01 January 2024 |
|
|
A pilot study of multi-dose faecal microbiota transplantation with antibiotic preconditioning for primary sclerosing cholangitis |
|
|
The Queen Elizabeth Hospital, Gastroenterology, Woodville South |
|
|
2023 GESA Rose Amarant Grant |
Rose Amarant |
Rupert W Leong |
$7,500 exc. |
6 months |
01 October 2023 |
|
|
Persistence Australian National IBD Cohort (PANIC): Evaluation of the 100 Pharmaceutical Benefits Scheme Data for Crohns Disease and Ulcerative Colitis |
|
|
Concord Hospital, Sydney, Concord West |
|
|
GESA Sustainability Grant Award 2023 |
GESA |
Christopher Leung |
$25,000 exc. |
12 months |
01 October 2023 |
|
|
Combating Climate Change with Education: Evolving to Choose Wisely and Gastroenterology Training |
|
|
Austin Health, Heidelberg |
|
|
2023 GESA Project Grant |
|
Lauren Andersson |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
Analysis of genomic and epigenomic modifications of cell free DNA within a single workflow in patients with hepatocellular carcinoma and chronic liver disease - a pilot study. |
|
|
Peter MacCallum Cancer Centre, North Melbourne |
|
|
2023 GESA Project Grant |
|
Zaid S Ardalan |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
A PROSPECTIVE STUDY OF THE UTILITY OF INTESTINAL ULTRASOUND AND FAECAL CALPROTECTIN IN THE DIAGNOSIS AND MONITORING OF IMMUNE CHECKPOINT INHIBITOR COLITIS |
|
|
Alfred Health, Melbourne |
|
|
2023 GESA Project Grant |
|
Benjamin J Dwyer |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
Data-based prediction of ideal extracellular culture environment to enable patient-derived organoid technology in clinical decision making for liver cancer. |
|
|
Curtin University, Bentley |
|
|
2023 GESA Project Grant |
|
Rimma Goldberg |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
Antigen Specific Regulatory T Cell Therapy for Inflammatory Bowel Disease |
|
|
Monash Health, Clayton |
|
|
2023 GESA Project Grant |
|
Sumaira Z Hasnain |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
Developing Pancreas-Targeted Interleukin-22 as a Therapeutic for Pancreatitis |
|
|
The University of Queensland, Saint Lucia |
|
|
2023 GESA Project Grant |
|
Claire Louise O Brien |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
CRISPR/Cas9 knockout of Escherichia coli genes found to be associated with Crohn's disease |
|
|
University of Canberra, Bruce |
|
|
2023 GESA Project Grant |
|
Zhihong Xu |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
Towards a Novel Therapeutic Approach for Alcoholic Chronic Pancreatitis |
|
|
University of New South Wales, Liverpool |
|
|
2023 GESA Project Grant |
|
CK Yao |
$50,000 exc. |
12 months |
27 September 2023 |
|
|
Investigating the therapeutic potential of a diet low in sulphite and carrageenan food additives for ulcerative colitis |
|
|
Monash University Department of Gastroenterology, Melbourne |
|
|
2023 GESA Bushell Post-doctoral Research Fellowship |
Bushell |
susan l woods |
$330,000 incl. |
3 years |
15 September 2023 |
|
|
NEXT GENERATION TREATMENT OF GASTRIC CANCER |
|
|
The University of Adelaide, Adelaide |
|
|
2023 GESA Lawrie Powell AC Grant Award |
GESA |
Sumaira Z Hasnain |
$25,000 exc. |
1 year |
16 June 2023 |
|
|
Investigating the Therapeutic Potential of Liver Targeted IL-22 in Reducing Endothelial to Mesenchymal Transition |
|
|
The University of Queensland, Saint Lucia |
|
|
2023 GESA Mostyn Family Grant |
GESA-Mostyn |
Chamini Perera |
$27,000 exc. |
12 months |
23 May 2023 |
|
|
Understanding the Role of Mediators Involved in Insulin Secretion and Insulin Signalling Pathways in Pancreatic Cancer-Related Diabetes: Potential Biomarkers of Pancreatic Cancer |
|
|
UNSW Sydney, Randwick |
|
|
2023 GESA Dr Falk Pharma Research Grant |
Dr Falk Pharma |
Scott Nightingale |
$30,000 incl. |
12 months |
01 January 2023 |
|
|
Food antigen stimulation of oesophageal organoids from children with eosinophilic oesophagitis can triggers be identified in vitro? |
|
|
John Hunter Children's Hospital, New Lambton Heights |
|
|
2022 GESA Project Grant |
|
Leon A Adams |
$50,000 incl. |
12 months |
10 October 2022 |
|
|
Assessing the gut microbiome associated with metabolic-dysfunction fatty liver disease (MAFLD) |
|
|
University of Western Australia, Nedlands |
|
|
2022 GESA Project Grant |
|
Catherine Bond |
$50,000 incl. |
12 months |
10 October 2022 |
|
|
Organoid co-culture modelling to assess efficacy of a novel sequential therapy for aggressive colorectal cancers |
|
|
QIMR Berghofer Medical Research Institute, Herston |
|
|
2022 GESA Project Grant |
|
Craig Haifer |
$50,000 incl. |
12 months |
10 October 2022 |
|
|
Orally Administered Faecal Microbial Transplantation in the Management of Immune Checkpoint Inhibitor Associated Colitis - A randomised control trial to assess safety and preliminary efficacy |
|
|
St Vincent's Hospital Sydney, Darlinghurst |
|
|
2022 GESA Project Grant |
|
Nathan Subramaniam |
$50,000 incl. |
12 months |
10 October 2022 |
|
|
Analysis of novel genes associated with non-alcoholic fatty liver disease |
|
|
Queensland University of Technology, Kelvin Grove |
|
|
2022 GESA Project Grant |
|
Thomas Tu |
$50,000 incl. |
12 months |
10 October 2022 |
|
|
Targeting viral reservoirs in chronic hepatitis B to cure chronic infection |
|
|
Westmead Institute for Medical Research, Westmead |
|
|
2022 GESA Members Research Grant |
GESA |
Alan J Wigg |
$13,950 exc. |
12 months |
01 October 2022 |
|
|
Prevalence of risk factors for liver disease and advanced fibrosis in a remotely living adult Aboriginal population |
|
|
Flinders Medical Centre, Bedford Park |
|
|
2022 Rose Amarant Grant |
GESA |
Mark Ward |
$5,000 incl. |
6 months |
30 September 2022 |
|
|
Quantifying bound anti-drug antibodies to anti-TNF therapy using a drug tolerant assay can predict subsequent immunogenic failure when de-escalating from combination therapy to anti-TNF monotherapy |
|
|
Alfred Health, Melbourne |
|
|
2022 GESA Mostyn Family Grant |
GESA-Mostyn |
Daniel Enosi Tuipulotu |
$30,000 incl. |
12 months |
19 May 2022 |
|
|
Innate immune sensing in the development of colorectal cancer |
|
|
John Curtin School of Medical Research, ANU, Acton |
|
|
2022 GESA Dr Falk Pharma Research Grant |
Dr Falk Pharma |
Sumaira Z Hasnain |
$30,000 incl. |
12 months |
02 February 2022 |
|
|
Can Targeting Interleukin-24 Resolve Intestinal Fibrosis in Inflammatory Bowel Disease? |
|
|
The University of Queensland, Varsity Lakes |
|
|
2022 GESA Celltrion Healthcare IBD Fellowship |
Celltrion |
Aysha Husam Al-Ani |
$30,000 incl. |
12 months |
31 January 2022 |
|
|
Multiplexed Imaging to Predict Outcomes in Acute Severe Ulcerative Colitis |
|
|
Royal Melbourne Hospital, Parkville |
|
|
2021 GESA Project Grant |
GESA |
Rodrigo Carlessi |
$30,000 incl. |
1 year |
06 September 2021 |
|
|
Methylation signature of precancerous hepatocytes in circulating free DNA (cfDNA) as a new biomarker to predict hepatocellular carcinoma prior to its development |
|
|
Curtin University, Bentley |
|
|
2021 GESA Project Grant |
GESA |
Lochlan John Fennell |
$30,000 incl. |
1 year |
06 September 2021 |
|
|
Microbes and Malignancy: Deciphering the host-microbe interactions of Fusobacterium Nucleatum via Spatial Transcriptomics |
|
|
QIMR Berghofer, Herston |
|
|
2021 GESA Project Grant |
GESA |
Jacinta Alison Holmes |
$30,000 incl. |
1 year |
06 September 2021 |
|
|
Novel methods to assess and define portal hypertension: tools to improve clinical outcomes in patients with cirrhosis |
|
|
St Vincent's Hospital, Fitzroy |
|
|
2021 GESA Project Grant |
GESA |
Charlotte Y Keung |
$30,000 incl. |
1 year |
06 September 2021 |
|
|
Beyond visible endoscopy: a point-of-care biochemical imaging for inflammation and fibrosis in IBD using near-infrared spectroscopy |
|
|
Monash University, Clayton |
|
|
2021 GESA Project Grant |
GESA |
Yong Hua Sheng |
$30,000 incl. |
1 year |
06 September 2021 |
|
|
Examining the Therapeutic Potential of MUC1 Inhibition in Inflammatory Bowel Disease |
|
|
Mater Research Institute, Woolloongabba |
|
|
2021 Rose Amarant Grant |
Rose Amarant |
Britt Christensen |
$5,000 incl. |
6 months |
06 September 2021 |
|
|
Immune response to SARS-CoV-2 vaccination in immunocompromised hosts (IRVAX) |
|
|
Royal Melbourne Hospital, Parkville |
|
|
2021 GESA Boston Scientific Endoscopy Fellowship |
Boston Scientific |
Kevin Kyung Ho Choi |
$40,000 incl. |
12 months |
23 August 2021 |
|
|
Innovative and Disruptive Endoscopic Techniques for Enhancing Patient Outcomes |
|
|
Gastroenterology Dept Royal Prince Alfred Hospital, Camperdown |
|
|
2021 GESA Members Philanthropic Grant |
GESA |
Finlay Alistair Macrae |
$10,000 incl. |
1 year |
19 April 2021 |
|
|
Professional learning visits and AGW attendance for senior Solomon Islands physician Dr Elizabeth Wore |
|
|
ANZGITA, Parkville |
|
|
2021 GESA Mostyn Family Grant |
Mostyn |
Yong Hua Sheng |
$30,000 incl. |
1 year |
19 April 2021 |
|
|
Targeting MUC1 Cell Surface Mucin to Sensitise Colorectal Cancer to Therapy |
|
|
Mater Research Institute, Woolloongabba |
|
|
2021 GESA Olympus Endoscopy Fellowship |
Olympus |
Andrew Trinh |
$20,000 incl. |
1 year |
30 January 2021 |
|
|
Investigating the Diagnosis, Characteristics and Management of Low Phospholipid Associated Cholelithiasis |
|
|
Royal Melbourne Hospital, Gastroenterology, Parkville |
|
|
2020 GESA Project Grants |
GESA |
Rimma Goldberg |
$25,000 incl. |
1 year |
30 November 2020 |
|
|
Restoring Protective Immunity in Inflammatory Bowel Disease |
|
|
Monash Health, Clayton |
|
|
2020 GESA Project Grants |
GESA |
Lionel Hebbard |
$25,000 incl. |
1 year |
30 November 2020 |
|
|
Determining the role of a novel gene in liver cancer |
|
|
James Cook University, Douglas |
|
|
2020 GESA Project Grants |
GESA |
Nadeem O Kaakoush |
$25,000 incl. |
1 year |
30 November 2020 |
|
|
Immunoglobulin A degradation by the gut microbiome |
|
|
University of New South Wales, Kensington |
|
|
2020 GESA Project Grants |
GESA |
Avik Majumdar |
$25,000 incl. |
1 year |
30 November 2020 |
|
|
Exploring the pathogenesis of cardiac dysfunction in advanced chronic liver disease with metabolomic profiling |
|
|
Royal Prince Alfred Hospital, Camperdown |
|
|
2020 GESA Project Grants |
GESA |
Nathan Subramaniam |
$25,000 incl. |
1 year |
30 November 2020 |
|
|
Identification of biomarkers in liver disease progression using spatial transcriptomics |
|
|
Queensland University of Technology, Kelvin Grove |
|
|
2020 GESA Project Grants |
GESA |
Ran Wang |
$25,000 incl. |
1 year |
30 November 2020 |
|
|
Development of a Novel Inhibitor of IL-23p19 for treating Inflammatory Bowel Disease |
|
|
The University of Queensland, Woolloongabba |
|
|
2020 GESA Project Grants |
GESA |
Hui Emma Zhang |
$25,000 incl. |
1 year |
30 November 2020 |
|
|
Targeting a Unique Enzyme as a Novel Therapy for Primary Liver Cancer |
|
|
Centenary Institute, Camperdown |
|
|
2020 GESA Members Research Grant |
GESA |
Robert Venning Bryant |
$7,350 incl. |
1 year |
28 November 2020 |
|
|
Inflammatory bowel disease (IBD) in a town like Alice: establishing a best practice IBD service using a novel software platform |
|
|
The Quen Elizabeth Hospital, Woodville South |
|
|
2020 Rose Amarant Grant |
Rose Amarant |
Astrid-Jane Williams |
$5,000 incl. |
6 months |
03 November 2020 |
|
|
Paediatric to Adult Transition in Inflammatory Bowel Disease Care: A Pilot Study of a Structured Clinical Pathway in an Adult Service |
|
|
Liverpool Hospital, Liverpool |
|
|
2020 GESA-Ferring IBD Clinical Excellence Grants |
Ferring |
Craig Haifer |
$30,000 incl. |
1 year |
01 June 2020 |
|
|
Lyophilised Oral Faecal Microbiota Transplantation in Ulcerative Colitis (LOTUS Study) |
|
|
St Vincent's Hospital, Darlinghurst |
|
|
2020 GESA-Ferring IBD Clinical Excellence Grants |
Ferring |
Ola Niewiadomski |
$30,000 incl. |
1 year |
01 June 2020 |
|
|
Incorporation of Evidence-Based Practical Dietary Therapy into Inflammatory Bowel Disease Care |
|
|
St Vincent's Hospital, Melbourne, Fitzroy |
|
|
2020 GESA-Ferring IBD Clinical Excellence Grants |
Ferring |
Astrid-Jane Williams |
$30,000 incl. |
1 year |
01 June 2020 |
|
|
Establishment of a Pregnancy in Inflammatory Bowel Disease Multi-Disciplinary Service at Liverpool Hospital |
|
|
Liverpool Hospital Gastroenterology Department, Liverpool |
|
|
2019 GESA Members Research Grant |
GESA |
Alan J Wigg |
$20,725 incl. |
1 year |
01 October 2019 |
|
|
Hepatocellular Carcinoma within ATSI populations of South Australia and Northern Territory |
|
|
Flinders Medical Centre, Bedford Park |
|
|
2019 GESA Project Grant |
GESA |
Natalia Castano Rodriguez |
$25,000 incl. |
1 year |
01 October 2019 |
|
|
Dysregulated autophagy contributes to gastric carcinogenesis via the gastric microbiome |
|
|
UNSW Sydney, Kensington |
|
|
2019 GESA Project Grant |
GESA |
Charles Cock |
$25,000 incl. |
1 year |
01 October 2019 |
|
|
Utility of Mucosal Impedance for the Diagnosis of Eosinophilic Oesophagitis during Oesophageal High-Resolution Manometry |
|
|
Flinders Medical Centre Gastroenterology, Bedford Park |
|
|
2019 GESA Project Grant |
GESA |
Caryn L Elsegood |
$25,000 incl. |
1 year |
01 October 2019 |
|
|
Novel inflammatory monocyte subsets intrinsically regulate the severity of hepatic injury |
|
|
Curtin University, Bentley |
|
|
2019 GESA Project Grant |
GESA |
Patrick A Hughes |
$25,000 incl. |
1 year |
01 October 2019 |
|
|
ImmunoPET of biologics in humanized colitis: Towards theranostic treatment of Inflammatory Bowel Disease. |
|
|
University of Adelaide, Adelaide |
|
|
2019 GESA Project Grant |
GESA |
Michelle V Melino |
$25,000 incl. |
1 year |
01 October 2019 |
|
|
Understanding the link between peroxisome dysfunction and chronic liver disease |
|
|
Queensland University of Technology, Kelvin Grove |
|
|
2019 GESA Project Grant |
GESA |
John Olynyk |
$25,000 incl. |
1 year |
01 October 2019 |
|
|
Single nucleus sequencing of matched chronically injured liver tissue - A ground-breaking new opportunity for biomarker discovery in liver cancer research |
|
|
Fiona Stanley Hospital, Murdoch |
|
|
2019 GESA Project Grant |
GESA |
Tony Pang |
$25,000 incl. |
1 year |
01 October 2019 |
|
|
Circulating tumour cell culture in pancreatic cancer using novel Rare Cell Spin device |
|
|
Pancreatic Research Group, UNSW, Liverpool |
|
|
2019 GESA Rose Amarant Grant |
Rose Amarant |
Astrid-Jane Williams |
$5,000 incl. |
6 months |
01 October 2019 |
|
|
Shared Decision Making in Pregnancy in Inflammatory Bowel Disease: Design of a Decision Aid to Assist Patients make informed decisions regarding the management of IBD during Pregnancy |
|
|
Liverpool Hospital Gastroenterology Department, Liverpool |
|
|
2019 GESA Bushell Post-doctoral Research Fellowship |
Bushell |
Ran Wang |
$240,000 incl. |
3 years |
01 January 2019 |
|
|
Targeting TH17 inflammatory response to suppress intestinal inflammation |
|
|
The University of Queensland, Saint Lucia |
|
|
2018 Rose Amarant Grant |
Rose Amarant |
Nik Ding |
$5,000 incl. |
6 months |
01 November 2018 |
|
|
None provided |
|
|
St Vincent's Hospital Melbourne, Fitzroy |
|
|
2018 GESA Research Collaboration Grants |
GESA |
Gregory J Anderson |
$50,000 incl. |
1 year |
11 September 2018 |
|
|
A project to use unbiased metabolomics and breathomics approaches to seek new biomarkers leading to a better understanding of the pathogenesis of MHE |
|
|
QIMR Berghofer Medical Research Institute, Herston |
|
|
2018 GESA Research Collaboration Grants |
GESA |
Sumaira Z Hasnain |
$50,000 incl. |
1 year |
11 September 2018 |
|
|
A study to determine the therapeutic potential of IL-22-ScFv to reverse liver steatosis in a preclinical model of NAFLD |
|
|
Mater Research Limited, South Brisbane |
|
|
2018 GESA Research Collaboration Grants |
GESA |
Rupert W Leong |
$50,000 incl. |
1 year |
11 September 2018 |
|
|
A project to establish a network of clinicians across NSW and ACT to recruit adult and paediatric patients into the Australian IBD Microbiome (AIM) study |
|
|
University of New South Wales, Randwick |
|
|
2018 GESA Research Collaboration Grants |
GESA |
Nicholas Adam Shackel |
$50,000 incl. |
1 year |
11 September 2018 |
|
|
A study to investigate the interaction between host genetics and the microbiome in the pathogenesis of PSC |
|
|
Ingham Institute, Liverpool |
|
|
2018 GESA Ferring IBD Clinical Project (FIP) Grant |
Ferring |
Chamara Basnayake |
$15,000 exc. |
1 year |
10 September 2018 |
|
|
Microbial Restoration in Inflammatory Bowel Disease (MIRO) Study |
|
|
St Vincent's Hospital Melbourne - Gastroenterology, Collingwood |
|
|
2018 GESA Ferring IBD Clinical Project (FIP) Grant |
Ferring |
Jakob Begun |
$15,000 exc. |
1 year |
10 September 2018 |
|
|
Establishment of an IBD Fertility and Maternity Service at the Mater Hospital Brisbane |
|
|
Mater Hospital Brisbane, South Brisbane |
|
|
2018 GESA Ferring IBD Clinical Project (FIP) Grant |
Ferring |
Britt Christensen |
$15,000 exc. |
1 year |
10 September 2018 |
|
|
A study to determine if ultrasonographic findings of disease activity can predict the primary outcome of clinical relapse in patients with IBD |
|
|
Royal Melbourne Hospital, North Melbourne |
|
|
2018 GESA Ferring IBD Clinical Project (FIP) Grant |
Ferring |
Peter R Gibson |
$15,000 exc. |
1 year |
10 September 2018 |
|
|
Impact of variations in storage temperature on the function and levels of subcutaneously administered monoclonal antibodies |
|
|
Alfred Hospital, Melbourne |
|
|
2018 GESA Seed Grants |
GESA |
Jessica Howell |
$45,500 incl. |
1 year |
10 September 2018 |
|
|
Overcoming barriers to survival in Liver Cancer: Circulating free tumour DNA-guided treatment of hepatocellular carcinoma |
|
|
St Vincent's Hospital Melbourne, Collingwood |
|
|
2018 GESA Seed Grants |
GESA |
Charlotte Y Keung |
$50,000 incl. |
1 year |
10 September 2018 |
|
|
A prospective human pilot study including 10 adults with medically refractory complex perianal Crohn's disease to evaluate the safety of hAEC therapy administered via local fistula injection |
|
|
Monash University, Clayton |
|
|
2018 GESA Seed Grants |
GESA |
Hamish Philpott |
$6,350 incl. |
1 year |
10 September 2018 |
|
|
A study to prospectively acquire tissue and serum to measure the ability of Syndecan-1 to gauge treatment response, prior to and after treatment, in patients with EoE |
|
|
Northern Adelaide Local Health Network, Elizabeth Grove |
|
|
2018 GESA Seed Grants |
GESA |
Gautam Rishi |
$29,821 incl. |
1 year |
10 September 2018 |
|
|
Targeting Fibrosis: Identification of novel natural compounds to modulate collagen expression |
|
|
Institute of Health and Biomedical Innovation, QUT, Kelvin Grove |
|
|
2018 GESA Seed Grants |
GESA |
Nina Tirnitz-Parker |
$18,329 incl. |
1 year |
10 September 2018 |
|
|
Identification of novel biomarker profiles for cancer stem cell-like liver progenitor cells and evaluation of their potential prognostic value in an innovative 3D bioprinting approach |
|
|
Curtin Health Innovation Research Institute, Bentley |
|
|
2018 GESA Members Research Grant |
GESA |
Jessica Howell |
$12,000 incl. |
1 year |
03 September 2018 |
|
|
Cancer versus Hepatitis B Information to Increase Acceptability of Hepatitis B testing in Chinese migrants: The CHINA-B Study |
|
|
St Vincent's Hospital Melbourne, Fitzroy |
|
|
2017 GESA Takeda IBD Research Project Award |
Takeda |
Nik Ding |
$25,000 incl. |
1 year |
01 October 2017 |
|
|
Sarcopenia as a Predictor of Non-response to Anti-TNF therapy in Crohn's Disease (SPARC) |
|
|
St Vincent's Hospital Melbourne, Fitzroy |
|
|
2017 GESA Takeda IBD Research Project Award |
Takeda |
Claire Louise O Brien |
$25,000 incl. |
1 year |
01 October 2017 |
|
|
Host-microbial cross-talk in Crohn's Disease |
|
|
ANU Medical School, Garran |
|
|
2017 GESA Ferring IBD Clinical Project Award |
Ferring |
Mark Ward |
$16,500 incl. |
1 year |
01 July 2017 |
|
|
A virtual clinic to co-ordinate compassionate intensified biologic therapy in patiemts with inflammatory bowel disease: Cost analysis and effectivenss compared to standard of care |
|
|
Alfred Hospital IBD Unit, Melbourne |
|
|
2017 GESA Research Collaboration Grants |
GESA |
Edward M Giles |
$30,000 incl. |
1 year |
01 July 2017 |
|
|
Characterisation of the microbiota composition in paediatric inflammatory bowel disease |
|
|
Hudson Institute of Medical Research, Clayton |
|
|
2017 GESA Ferring IBD Clinician Establishment (FICE) Grants |
Ferring |
Kavitha Subramaniam |
$60,000 incl. |
2 years |
01 January 2017 |
|
|
Setting up a Model of Care for adolescents transitioning to adult health care in IBD at the Canberra Hospital |
|
|
Canberra Hospital, Garran |
|